Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,946,220
  • Shares Outstanding, K 32,573
  • Annual Sales, $ 2,227 M
  • Annual Income, $ 209,070 K
  • 60-Month Beta 0.88
  • Price/Sales 1.86
  • Price/Cash Flow 15.36
  • Price/Book 4.03
Trade AMED with:

Options Overview Details

View History
  • Implied Volatility 53.63% ( +0.33%)
  • Historical Volatility 49.39%
  • IV Percentile 83%
  • IV Rank 62.74%
  • IV High 69.59% on 01/25/22
  • IV Low 26.76% on 06/09/21
  • Put/Call Vol Ratio 1.90
  • Today's Volume 29
  • Volume Avg (30-Day) 98
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 5,895
  • Open Int (30-Day) 6,755

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 1.24
  • Number of Estimates 8
  • High Estimate 1.31
  • Low Estimate 1.19
  • Prior Year 1.69
  • Growth Rate Est. (year over year) -26.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.53 +7.02%
on 05/10/22
147.99 -20.80%
on 04/28/22
-18.64 (-13.72%)
since 04/22/22
3-Month
109.53 +7.02%
on 05/10/22
179.91 -34.85%
on 03/29/22
-30.72 (-20.77%)
since 02/24/22
52-Week
109.53 +7.02%
on 05/10/22
276.21 -57.56%
on 07/07/21
-141.69 (-54.73%)
since 05/24/21

Most Recent Stories

More News
Five Top Global Home Healthcare Stocks to Consider in 2022

The global home healthcare market could be worth nearly $635 billion by 2030, says Grand View Research, which could be a significant catalyst for companies such as Quipt Home Medical Corp. (NASDAQ: QIPT)...

AMED : 117.21 (-3.25%)
LHCG : 165.81 (+0.04%)
SIS.TO : 13.61 (-2.09%)
SISXF : 10.6833 (-3.84%)
ADUS : 85.18 (+1.99%)
QIPT : 4.33 (-6.68%)
QIPT.VN : 5.595 (-0.09%)
Amedisys (AMED) New Buyouts Aid Growth, Margin Pressure Stays

Amedisys' (AMED) newly-formed high-acuity care segment experiences solid momentum in the first quarter.

UNH : 497.56 (+1.11%)
AMED : 117.21 (-3.25%)
ALKS : 28.35 (-3.24%)
OMCL : 109.39 (-1.38%)
Amedisys Celebrates National Nurses Week

BATON ROUGE, La., May 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care, palliative...

AMED : 117.21 (-3.25%)
Amedisys to Present at Multiple Healthcare Conferences in May

BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and...

AMED : 117.21 (-3.25%)
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Down

Impressive performance by the Home Health and Hospice segments drove Amedisys' (AMED) revenues in the first quarter.

UNH : 497.56 (+1.11%)
AMED : 117.21 (-3.25%)
QGEN : 45.55 (-0.74%)
CNC : 87.21 (+1.36%)
Amedisys (AMED) Q1 Earnings Top Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 10.81% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AMED : 117.21 (-3.25%)
ELAN : 23.17 (-2.20%)
Amedisys Reports First Quarter 2022 Financial Results and Reaffirms 2022 Guidance

BATON ROUGE, La., April 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended...

AMED : 117.21 (-3.25%)
The Top 5 Companies Benefiting from a Potential $839 Billion Home Healthcare Market

The global home healthcare market could be worth $839 billion by 2028, says Zion Market Research, which could be a significant catalyst for companies such as Quipt Home Medical Corp. (NASDAQ: QIPT) (TSXV:...

AMED : 117.21 (-3.25%)
LHCG : 165.81 (+0.04%)
SIS.TO : 13.61 (-2.09%)
SISXF : 10.6833 (-3.84%)
ADUS : 85.18 (+1.99%)
QIPT : 4.33 (-6.68%)
QIPT.VN : 5.595 (-0.09%)
Amedisys Announces First Quarter 2022 Earnings Release and Conference Call Date

BATON ROUGE, La., April 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and...

AMED : 117.21 (-3.25%)
Here's Why You Should Retain Amedisys (AMED) Stock For Now

Investors are optimistic about Amedisys' (AMED) strong segmental performance and strategic buyouts.

AMED : 117.21 (-3.25%)
OMI : 33.69 (-2.69%)
MCK : 328.80 (+0.36%)
NXGN : 17.90 (+1.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

3rd Resistance Point 123.52
2nd Resistance Point 121.71
1st Resistance Point 119.46
Last Price 117.21
1st Support Level 115.40
2nd Support Level 113.59
3rd Support Level 111.34

See More

52-Week High 276.21
Fibonacci 61.8% 212.54
Fibonacci 50% 192.87
Fibonacci 38.2% 173.20
Last Price 117.21
52-Week Low 109.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar